Influence of the Acidic Beverage Cola on the Absorption of the HCV Agent Velpatasvir in Healthy Volunteers Being Treated With the Proton Pump Inhibitor Omeprazole.
Phase of Trial: Phase I
Latest Information Update: 17 Jul 2019
Price : $35 *
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary) ; Omeprazole
- Indications Hepatitis C
- Focus Pharmacokinetics
- Acronyms COPA
- 17 Jul 2019 Results published in the Clinical Pharmacology and Therapeutics
- 21 Jan 2019 Status changed from not yet recruiting to completed.
- 04 May 2018 New trial record